AUD 0.09
(-2.17%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | -2.69 Million AUD | -100.0% |
2023 | 3.02 Million AUD | 287.72% |
2022 | 780.22 Thousand AUD | 0.0% |
2021 | - AUD | 100.0% |
2020 | -403.32 Thousand AUD | -55.54% |
2019 | -259.31 Thousand AUD | -3.58% |
2018 | -250.35 Thousand AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 FY | - AUD | -100.0% |
2024 Q1 | - AUD | -100.0% |
2024 Q3 | - AUD | 0.0% |
2024 Q4 | -2.69 Million AUD | 0.0% |
2024 Q2 | - AUD | 0.0% |
2023 Q3 | - AUD | 0.0% |
2023 FY | 3.02 Million AUD | 287.72% |
2023 Q4 | 3.02 Million AUD | 0.0% |
2023 Q1 | - AUD | -100.0% |
2023 Q2 | - AUD | 0.0% |
2022 Q1 | - AUD | 0.0% |
2022 FY | 780.22 Thousand AUD | 0.0% |
2022 Q4 | 780.22 Thousand AUD | 0.0% |
2022 Q3 | - AUD | 0.0% |
2022 Q2 | - AUD | 0.0% |
2021 Q3 | - AUD | 100.0% |
2021 Q2 | -81.52 Thousand AUD | 0.0% |
2021 Q1 | - AUD | 100.0% |
2021 FY | - AUD | 100.0% |
2021 Q4 | - AUD | 0.0% |
2020 FY | -403.32 Thousand AUD | -55.54% |
2020 Q4 | -403.32 Thousand AUD | 0.0% |
2020 Q3 | - AUD | 0.0% |
2020 Q1 | - AUD | 0.0% |
2019 FY | -259.31 Thousand AUD | -3.58% |
2018 FY | -250.35 Thousand AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Australian Clinical Labs Limited | 16.82 Million AUD | 116.021% |
Genetic Signatures Limited | 6.72 Million AUD | 140.107% |
Genetic Technologies Limited | 206.46 Thousand AUD | 1405.585% |
Healius Limited | 31.9 Million AUD | 108.45% |
Imagion Biosystems Limited | - AUD | Infinity% |
Integral Diagnostics Limited | 1.65 Million AUD | 263.272% |
INOVIQ Ltd | 17.83 Thousand AUD | 15217.582% |
Microba Life Sciences Limited | 2.24 Million AUD | 220.149% |
Monash IVF Group Limited | 8.17 Million AUD | 132.962% |
Rhythm Biosciences Limited | 57.77 Thousand AUD | 4765.794% |
Sonic Healthcare Limited | 208.83 Million AUD | 101.291% |